References
- National Institute for Health and Care Excellence. Chronic kidney disease in adults: assessment and management. 2015. cited 2019 Jan 28. Available from: https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations
- Willison A, Tully V, Davey P. All patients with diabetes should have annual UACR tests. Why is that so hard? BMJ Qual Improv Rep. 2016;5(1):u209185.w3747.
- National Institute for Health and Care Excellence. Type 1 diabetes in adults: diagnosis and management. NG17. cited 2019 May 10. Available from: https://www.nice.org.uk/guidance/ng17/chapter/1-Recommendations
- Healthcare Quality and Improvement Partnership. National chronic kidney disease audit. 2017. cited 2019 Jan 30. Available from: https://www.lshtm.ac.uk/media/9951
- Leddy J, Green JA, Yule C, et al. Improving proteinuria screening with mailed smartphone urinalysis testing in previously unscreened patients with hypertension: a randomized controlled trial. 2019;20(1):132.
- National Institute for Health and Care Excellence (NICE). Medical technologies evaluation programme: methods guide. London: NICE; 2011 April.
- Diabetes UK. Diabetes Prevalence 2017. 2017. cited 2019 Jan 30. Available from: https://www.diabetes.org.uk/professionals/position-statements-reports/statistics/diabetes-prevalence-2017
- Fraser S, Roderick P, Aitken G, et al. Chronic kidney disease, albuminuria and socioeconomic status in the Health Surveys for England 2009 and 2010. J Public Health. 2014;36(4):577–586.
- de Boer IH, Afkarian M, Rue TC, et al. Renal outcomes in patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol. 2014;25(10):2342–2350.
- Wu H-Y, Peng Y-S, Chiang C-K, et al. Diagnostic performance of random urine samples using albumin concentration vs ratio of albumin to creatinine for microalbuminuria screening in patients with diabetes mellitus: a systematic review and meta-analysisrandom urine samples for microalbuminuriarandom urine samples for microalbuminuria. JAMA Intern Med. 2014;174(7):1108–1115.
- McTaggart M, Newall R, Hirst J, et al. Diagnostic accuracy of point-of-care tests for detecting albuminuria: a systematic review and meta-analysis. Ann Inter Med. 2014;160(8):550–557.
- Boulware LE, Jaar BG, Tarver-Carr ME, et al. Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA. 2003;290(23):3101–3114.
- National Institute for Health and Care Excellence (NICE). Preoperative tests: routine tests for elective surgery. Appendix M. 2016. cited 2019 Feb 26. Available from: https://www.nice.org.uk/guidance/ng45/evidence/appendix-m-economic-considerations-for-delphi-pdf-87258149464
- Personal Social Services Research Unit (PSSRU). Unit costs of health & social care 2018. Canterbury: University of Kent; 2018.
- Kerr M, Bray B, Medcalf J, et al. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dialysis Transplantation. 2012;27(suppl_3):iii73–iii80.
- Kent S, Schlackow I, Lozano-Kühne J, et al. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease? BMC Nephrol. 2015;16(1):65.
- Farmer AJ, Stevens R, Hirst J, et al. Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment -systematic review and modelling of progression and cost-effectiveness. Health Technol Assess. 2014;18:14.
- The Kidney Failure Risk Equation. 2019. cited 2019 Jan 30. Available from: http://kidneyfailurerisk.com/
- Middleton RJ, Foley RN, Hegarty J, et al. The unrecognized prevalence of chronic kidney disease in diabetes. Nephrol Dial Transplant. 2006;21(1):88–92. doi:10.1093/ndt/gfi163.
- Palmer SC, Mavridis D, Navarese E, et al. Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis. Lancet. 2015;385(9982):2047–2056. doi:10.1016/S0140-6736(14)62459-4.
- Office for National Statistics. National life tables: England and Wales London. 2018. cited 2019 May 10. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/lifeexpectancies/datasets/nationallifetablesenglandreferencetables
- Fox CS, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012;380(9854):1662–1673.
- Matsushita K, Coresh J, Sang Y, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015;3(7):514–525.
- Wang H, Yang L, Wang F, et al. Strategies and cost-effectiveness evaluation of persistent albuminuria screening among high-risk population of chronic kidney disease. BMC Nephrol. 2017;18(1):135–525.
- Lee S, Shafe ACE, Cowie MR. UK stroke incidence, mortality and cardiovascular risk management 1999–2008: time-trendanalysis from the General Practice Research Database. BMJ Open. 2011;1(2):e000269.
- ISD Scotland. IC2 - Acute myocardial infarction incidence by year, health board, age group and sex for financial years 2006/07-2016/17. 2017. cited 2019 Jan 31. Available from: http://www.isdscotland.org/Health-Topics/Heart-Disease/Publications/data-tables2017.asp?id=2090#2090
- Tun NN, Arunagirinathan G, Munshi SK, et al. Diabetes mellitus and stroke: A clinical update. World J Diabetes. 2017;8(6):235–248.
- Chang Y-T, Wu J-L, Hsu -C-C, et al. Diabetes and end-stage renal disease synergistically contribute to increased incidence of cardiovascular events: a nationwide follow-up study during 1998–2009. Diabetes Care. 2014;37(1):277.
- Cherng Y-G, Lin C-S, Shih -C-C, et al. Stroke risk and outcomes in patients with chronic kidney disease or end-stage renal disease: two nationwide studies. Plos One. 2018;13(1):e0191155.
- Vlagopoulos PT, Tighiouart H, Weiner DE, et al. Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. J Am Soc Nephrol. 2005;16(11):3403.
- Strippoli GFM, Navaneethan SD, Johnson DW, et al. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ. 2008;336(7645):645–651.
- National Guideline Centre & SSNAP. Sentinel stroke national audit programme: cost and cost-effectiveness analysis. 2016. cited 2019 Jan 31. Available from: https://www.strokeaudit.org/SupportFiles/Documents/Health-Economics/Health-economic-report-March-2017-FINAL-DRAFT-(1).aspx
- Godfrey C, Ali S, Parrott S. Economic model of adult smoking related costs and consequences for England. Public Health Research Consortium. 2011. cited 2019 Jan 31. Available from: http://phrc.lshtm.ac.uk/papers/PHRC_A4-06_Final_Report.pdf
- Graziani MS, Gambaro G, Mantovani L, et al. Diagnostic accuracy of a reagent strip for assessing urinary albumin excretion in the general population. Nephrol Dialysis Transplantation. 2008;24(5):1490–1494.
- McTaggart MP, Price CP, Pinnock RG, et al. The diagnostic accuracy of a urine albumin-creatinine ratio point-of-care test for detection of albuminuria in primary care. Am J Kidney Diseases. 2012;60(5):787–794.
- Park JI, Baek H, Kim BR, et al. Comparison of urine dipstick and albumin: creatinineratio for chronic kidney disease screening: A population-based study. PloS One. 2017;12(2):e0171106–e.
- NHS England. Harnessing technology and innovation. 2019. cited 2019 May 7. Available from: https://www.england.nhs.uk/five-year-forward-view/next-steps-on-the-nhs-five-year-forward-view/harnessing-technology-and-innovation/